Proxy Votes Now

Home › Activist investors › Anson Funds

Anson Funds

Campaign activist. Positions and campaigns from Anson Funds’s SEC filings. Updated November 20, 2026.

Filer entities
Anson Funds Management LP; Anson Capital, Inc.
SEC CIKs
1491072 (Anson Funds Management LP); 1906003 (Anson Capital, Inc.)
SEC filings
Schedule 13D filings · 13F reports · soliciting material
Latest 13F
Quarter ended Sep 30, 2026, filed Nov 13, 2026: 108 US-listed positions reported; 11 of 1% or more of a company without a 13D are listed below.
12current positions
9new or changed in 90 days; 5 exited
0active campaigns
5campaigns on record

Active campaigns

No active campaign by this definition (see How to read this).

Current positions (12)

CompanyStakeSourceFirst disclosedLast changeSince previous filingFlagsStated intent
22ND Century Group Inc. 11.20%80,000 shares 13F, quarter ended Sep 30, 2026filed Nov 13, 2026; % of shares outstanding as of Aug 14, 2026 Feb 14, 2017 Increased Nov 13, 2026 ▲ 6.36 pts Increased 13F: none stated
Venu Holding Corp. 8.60%4,836,290 shares 13F, quarter ended Sep 30, 2026filed Nov 13, 2026; % of shares outstanding as of Aug 13, 2026 May 14, 2026 Decreased Nov 13, 2026 ▼ 0.29 pts Decreased 13F: none stated
Kartoon Studios, Inc. 7.73%4,809,834 shares 13F, quarter ended Sep 30, 2026filed Nov 13, 2026; % of shares outstanding as of Aug 13, 2026 May 15, 2017 Decreased Nov 13, 2026 ▼ 0.62 pts Decreased 13F: none stated
Silo Pharma Inc. 4.82%103,983 shares 13F, quarter ended Sep 30, 2026filed Nov 13, 2026; % of shares outstanding as of Nov 13, 2026 Nov 13, 2026 — — New 13F: none stated
BlockchAIn Digital Infrastructure, Inc. 3.89%2,959,043 shares 13F, quarter ended Sep 30, 2026filed Nov 13, 2026; % of shares outstanding as of Aug 13, 2026 Aug 13, 2026 Decreased Nov 13, 2026 ▼ 0.09 pts Decreased 13F: none stated
SPS Commerce Inc. 2.63%930,510 shares 13F, quarter ended Sep 30, 2026filed Nov 13, 2026; % of shares outstanding as of Oct 22, 2026 May 14, 2026 Increased Nov 13, 2026 ▲ 0.56 pts Increased 13F: none stated
Lionsgate Studios Corp. 2.03%6,039,609 shares 13F, quarter ended Sep 30, 2026filed Nov 13, 2026; % of shares outstanding as of Nov 2, 2026 Aug 14, 2025 Increased Nov 13, 2026 ▲ 0.57 pts Increased 13F: none stated
The E.W. Scripps Company 1.94%1,738,804 shares 13F, quarter ended Sep 30, 2026filed Nov 13, 2026; % of shares outstanding as of Mar 31, 2026 Nov 13, 2026 — — New 13F: none stated
Catheter Precision Inc. 1.32%189,281 shares 13F, quarter ended Sep 30, 2026filed Nov 13, 2026; % of shares outstanding as of Aug 10, 2026 Nov 13, 2026 — — New 13F: none stated
Fgi Industries LTD. 38.37%740,991 shares 13F, quarter ended Sep 30, 2026filed Nov 13, 2026; % of shares outstanding as of Aug 10, 2026 May 12, 2022 — 0.00 pts — 13F: none stated
Lovesac Co 7.1%1,045,665 shares Schedule 13D/A, filed Apr 14, 2025 Jul 9, 2024 Increased Apr 14, 2025 ▲ 1.10 pts — Seeks changes or engagement
Five9, Inc. 3.32%2,499,481 shares 13F, quarter ended Sep 30, 2026filed Nov 13, 2026; % of shares outstanding as of Oct 30, 2026 Nov 16, 2020 — ▼ 0.03 pts — 13F: none stated

Stake: the latest 13D’s percent of the class (the largest single reporting person’s, as filed), or for a 13F the reported shares as a percent of the company’s shares outstanding on the date shown. Since previous filing: the change in percentage points against the investor’s previous 13D on the company, or its previous 13F.

Stated intent (13D Item 4)

Item 4 of a Schedule 13D (“Purpose of Transaction”) is where the investor states its plans. The label is a plain reading of that text; the excerpt is quoted from the filing.

Lovesac Co · Seeks changes or engagement

“business of the Issuer, management, board composition, investor communications, operations, capital allocation, dividend policy, financial condition, mergers and acquisitions strategy and strategic plans, overall business strategy, executive compensation, and corporate governance matters related to the Issuer’s business and stakeholders. The Reporting Persons may also have similar conversations with other stockholders or other third parties, such”

Item 4 in the Schedule 13D/A filed Apr 14, 2025; this amendment did not restate Item 4, so the text is from the filing of Jul 9, 2024.

Campaigns are compiled from SEC filings (13D, proxy contest filings and settlement 8-Ks); campaigns run without SEC filings, e.g. by public letter below the 5% threshold, may not appear.

Past campaigns (5)
CompanyOutcome or last statusDateFirst filingHighest stageFilingsMeeting / votes
SPS Commerce Inc. Settled (agreement with the company) Feb 12, 2026 Feb 12, 2026 — latest (1) —
MEI Pharma, Inc.Board seats Stake reported below 5% Jul 24, 2025 May 30, 2023 Proxy contest filed latest (17) —
Match Group, Inc.Board seats Contested vote held; result: see the company's 8-K Jun 18, 2025 Apr 4, 2025 Proxy contest filed (preliminary proxy) latest (3) —
Five9, Inc. Settled (agreement with the company) Dec 9, 2024 Dec 9, 2024 — latest (1) —
Twilio Inc Shareholder meeting held after the soliciting material Apr 24, 2024 Apr 4, 2024 Soliciting material filed latest (2) —
Past positions (8)
CompanyLast stakeSourceOutcomeDate
Creative Medical Technology Holdings, Inc. 1.60% 13F, quarter ended Jun 30, 2026filed Aug 13, 2026; % of shares outstanding as of Aug 7, 2026 Not in the latest 13F Nov 13, 2026
SELLAS Life Sciences Group, Inc. 2.23% 13F, quarter ended Jun 30, 2026filed Aug 13, 2026; % of shares outstanding as of Aug 10, 2026 Not in the latest 13F Nov 13, 2026
Solidion Technology Inc. 2.82% 13F, quarter ended Jun 30, 2026filed Aug 13, 2026; % of shares outstanding as of Aug 5, 2026 Not in the latest 13F Nov 13, 2026
Sono Group N.V. 9.97% 13F, quarter ended Jun 30, 2026filed Aug 13, 2026; % of shares outstanding as of Aug 1, 2026 Not in the latest 13F Nov 13, 2026
Imperial Petroleum Inc./Marshall Islands 3.54% 13F, quarter ended Jun 30, 2026filed Aug 13, 2026; % of shares outstanding as of Dec 31, 2025 Not in the latest 13F Nov 13, 2026
MEI Pharma, Inc. 3.7% Schedule 13D/A, filed Jul 24, 2025 Reported below 5% in a 13D/A Jul 24, 2025
Nano Dimension Ltd. 4.2% Schedule 13D/A, filed Jul 14, 2025 Reported below 5% in a 13D/A Jul 14, 2025
View, Inc. 9.9% Schedule 13D/A, filed Apr 5, 2024 Not in the 13F for the quarter ended Jun 30, 2024 Aug 13, 2024

How large managers voted in Anson Funds’s proxy contests (meetings since July 2023)

Fund votes come from Form N-PX filings, which this site holds from July 1, 2023 (meetings through June 30, 2026; later meetings appear when the managers file their next N-PX); earlier contests and campaigns that settled before a vote are listed under the activist’s campaigns.

No proxy contest has gone to a vote since July 1, 2023.

Track record

How each campaign on record ended, as read from the filings: settlements disclosed in the company’s 8-K or the investor’s 13D, contested votes (8-K Item 5.07), withdrawals and 13D amendments below 5%.

3Settlement
2No outcome in the filings read
Outcome of each campaign (5)
CompanyOutcomeDetailDateFirst filing
SPS Commerce Inc. Settlement agreement with the company Feb 12, 2026 Feb 12, 2026
MEI Pharma, Inc. Settlement agreement with the company Jul 22, 2025 May 30, 2023
Match Group, Inc. No outcome in the filings read — Jun 18, 2025 Apr 4, 2025
Five9, Inc. Settlement agreement with the company Dec 9, 2024 Dec 9, 2024
Twilio Inc No outcome in the filings read — Apr 24, 2024 Apr 4, 2024

Share price after the first 13D

The change in the company’s closing share price from the first trading day on or before the investor’s first Schedule 13D to the latest close, and to 6 and 12 months after it, beside the S&P 500 (SPY) over the same dates. This is a price change after a filing date: it is not attributed to the investor, and it is not the investor’s return. Coverage: 0 of 4 13D positions have prices (the site’s daily price history starts November 10, 2025, and covers only listed tickers it tracks).

Settlement terms

Terms of the cooperation agreements, read by rules from the company’s Form 8-K (or the investor’s 13D where it describes the agreement). Each term is quoted from the filing; terms a rule did not find are not listed, so a missing term is not evidence that the agreement lacks it.

SPS Commerce Inc. · Feb 12, 2026 · Directors named
MEI Pharma, Inc. · Jul 22, 2025 · Directors named, Standstill

Other disclosed holders around the same time

Filings by other activists on this list (their first 13D or 13F on the company) and by other holders of 5% or more (Schedule 13D or 13G) dated within 180 days of Anson Funds’s first disclosure in the same company. They are listed together by date only; nothing here says the holders act together.

BlockchAIn Digital Infrastructure, Inc. · Anson Funds first disclosed Aug 13, 2026 · 2 other filings
HolderFormDateStake
Tiger Cloud LLC Schedule 13D Mar 23, 2026 69.9%
Oasis Management 13F Nov 16, 2026 1.7%
Creative Medical Technology Holdings, Inc. · Anson Funds first disclosed Aug 13, 2026 · 1 other filing
HolderFormDateStake
Timothy Warbington Schedule 13D Oct 1, 2026 13.7%
SPS Commerce Inc. · Anson Funds first disclosed May 14, 2026 · 5 other filings
HolderFormDateStake
Irenic Capital 13F Feb 17, 2026 1.7%
Vanguard Portfolio Management Schedule 13G Apr 29, 2026 8.0%
Vanguard Capital Management Schedule 13G Apr 30, 2026 5.3%
Engine Capital 13F Aug 14, 2026 2.6%
Disciplined Growth Investors Inc /Mn Schedule 13G Aug 14, 2026 5.9%
Venu Holding Corp. · Anson Funds first disclosed May 14, 2026 · 1 other filing
HolderFormDateStake
Nantahala Capital 13F May 15, 2026 2.8%
Lionsgate Studios Corp. · Anson Funds first disclosed Aug 14, 2025 · 3 other filings
HolderFormDateStake
Liberty Global Ltd. Schedule 13D May 8, 2025 2.5%
MHR Institutional Partners III LP Schedule 13D May 8, 2025 13.3%
Liberty 77 Capital L.P. Schedule 13D May 12, 2025 9.5%
Match Group, Inc. · Anson Funds first disclosed Apr 4, 2025 · 3 other filings
HolderFormDateStake
Starboard Value 13F Nov 14, 2024 2.5%
BlackRock, Inc. Schedule 13G Apr 17, 2025 6.3%
Ameriprise Financial, Inc. Schedule 13G Aug 14, 2025 5.1%
Solidion Technology Inc. · Anson Funds first disclosed May 14, 2024 · 1 other filing
HolderFormDateStake
Global Graphene Group, Inc. Schedule 13D Feb 6, 2024 90.4%
Imperial Petroleum Inc./Marshall Islands · Anson Funds first disclosed Nov 14, 2023 · 1 other filing
HolderFormDateStake
Flawless Management Inc. Schedule 13D Aug 4, 2023 26.5%
View, Inc. · Anson Funds first disclosed Oct 26, 2023 · 2 other filings
HolderFormDateStake
CF Finance Holdings II, LLC Schedule 13D Oct 26, 2023 6.0%
RXR Realty LLC Schedule 13D Oct 26, 2023 5.0%

How to read this

Flags (last 90 days)
New first disclosed in the last 90 days. Increased / Decreased shares up or down in a 13D/A or 13F filed in that time. Below 5% a 13D/A reported less than 5%, the reporting threshold. Exited a 13D/A reported no shares, or the investor’s 13F no longer lists a company it listed before.
Active campaign
A contested meeting at which the investor is soliciting proxies is still to be held; or in the last 12 months it filed a proxy-contest document (PREC14A, DEFC14A or DFAN14A soliciting material), stated in a 13D that it nominated directors, filed a letter or presentation to the board or shareholders, or stated public demands in a 13D — and no settlement, withdrawal, contested vote or 13D below 5% is dated on or after the latest such filing. Status is the furthest step since then: Public demands in a 13D < Public letter or soliciting material < Nominations made < Proxy contest filed.
Sources and limits
SEC EDGAR only. 13D data covers filings since June 2023; 13F reports are quarterly and filed up to 45 days after the quarter, and do not show swaps, most options or non-US holdings. Settlements are cooperation agreements disclosed in the company’s 8-K or stated in the investor’s 13D; board seats are read from the 8-K. Text marked Summary of the filing is checked against the filing, whose words are quoted beside it. Nothing on this page predicts what the investor will do.